How to buy TC BioPharm Holdings stock

TC BioPharm Holdings PLC is a biotechnology business based in the US. TC BioPharm Holdings shares (TCBP) are listed on the NASDAQ and all prices are listed in US Dollars. TC BioPharm Holdings employs 76 staff and has a trailing 12-month revenue of around 0.00.

Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

TC BioPharm Holdings stock price (NASDAQ: TCBP)

Use our graph to track the performance of TCBP stocks over time.

TC BioPharm Holdings shares at a glance

• Key figures

Information last updated 2022-06-28.

Latest market close	$0.37
52-week range	$0.33 - $3.50
50-day moving average more info button	$0.87
200-day moving average more info button	$1.07
Wall St. target price	$5.00
PE ratio more info button	N/A
Dividend yield more info button	$0 (0%)
Earnings per share (TTM) more info button	$-0.85

Buy TC BioPharm Holdings shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy TC BioPharm Holdings stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

TC BioPharm Holdings price performance over time

Historical closes compared with the close of $0.368 from 2022-06-30

1 week (2022-06-24)	-5.40%
1 month (2022-06-01)	-44.33%
3 months (2022-04-01)	-72.94%
6 months (2021-12-28)	N/A

1 year (2021-06-27)	N/A
2 years (2020-06-27)	N/A
3 years (2019-06-27)	N/A
5 years (2017-06-27)	N/A

TC BioPharm Holdings financials

Revenue TTM	$2 million
Gross profit TTM	$2 million
Return on assets TTM	-59.57%
Return on equity TTM	0%
Profit margin	0%
Book value	N/A
Market capitalisation more info button	$11.2 million

TTM: trailing 12 months

TC BioPharm Holdings share dividends

We're not expecting TC BioPharm Holdings to pay a dividend over the next 12 months.

You may also wish to consider:

• Gilead Sciences (GILD.US) (4.63% forward annual dividend yield)

TC BioPharm Holdings overview

TC Biopharm (Holdings) Plc, a clinical-stage biopharmaceutical company, focuses on developing immunotherapy products based on its allogeneic gamma delta T cell platform. Its product pipeline includes OmnImmune, an unmodified cell therapy used in the treatment of acute myeloid leukemia; and ImmuniStim, an unmodified cell therapy to treat COVID-19. The company was founded in 2013 and is headquartered in Motherwell, the United Kingdom. .

Frequently asked questions

What percentage of TC BioPharm Holdings is owned by insiders or institutions?
Currently 28.991% of TC BioPharm Holdings shares are held by insiders and 12.379% by institutions. How many people work for TC BioPharm Holdings?
Latest data suggests 76 work at TC BioPharm Holdings. When does the fiscal year end for TC BioPharm Holdings?
TC BioPharm Holdings's fiscal year ends in December. Where is TC BioPharm Holdings based?
TC BioPharm Holdings's address is: Maxim 1, Motherwell, United Kingdom, ML1 4WR What is TC BioPharm Holdings's ISIN number?
TC BioPharm Holdings's international securities identification number is: US87807D1037